Company Overview and News

Mainland consumers to spend more on health, experience, premium products in 2018, experts say

2017-12-27 scmp
Companies that can tap into the growing trend among mainland consumers for healthy options should do well in 2018, analysts say

Mengniu Dairy looks to yoghurt beverages, acquisitions and a growing Chinese consumer appetite

2017-05-03 scmp
Potential mergers and acquisitions along with new product development may help China Mengniu Dairy, the second largest player in the country’s dairy market, to generate better profit and income this year after a drop in 2016, according to one analyst.

Three Chinese companies eye strategic stakes in FGV

FGV shares were actively traded since early trade yesterday. Price went from a low of RM1.93 to a high of RM2.18 before closing 18 sen or 9.42% higher at RM2.09. FGV is the world’s largest crude palm oil (CPO) producer with a market capitalisation of about RM7.62bil.

Mengniu pays HK$6.92 billion to buy out China’s largest dairy herd

2017-01-05 scmp
Mengniu Dairy, the country’s second-largest dairy producer, said it will pay a 3 per cent premium to market price to buy out an associate that controls China’s largest cattle herd, solidifying its grip on milk supplies amid an intensifying battle for market share with larger competitor Inner Mongolia Yili Industrial.

La conférence de presse portant sur l'indice d'évaluation commerciale des sportifs chinois s'est tenue le 17 décembre

2016-12-26 prnewswire
PÉKIN, 26 décembre 2016 /PRNewswire/ -- Une conférence de presse intitulée « l'indice de valeur commerciale des sportifs chinois » et placée sous le thème « Stars Allianz Index & New Value », qui a été conjointement organisée par China Youth Care Foundation et Stars Allianz of Sports and Media (Beijing) Co.Ltd., s'est tenue au centre d'échanges internationaux de l'université de communication de Chine le 17 décembre 2016.

El 17 de diciembre se realizó una conferencia de prensa sobre el índice del valor comercial de los atletas de China

2016-12-26 prnewswire
BEIJING, 26 de diciembre de 2016 /PRNewswire/ -- El 17 de diciembre de 2016, en el Centro de Intercambio Internacional de la Universidad de la Comunicación de China, organizada por la China Youth Care Foundation y la Stars Allianz of Sports and Media (Beijing) Co. Ltd., se realizó una conferencia de prensa titulada "Índice del valor comercial de los atletas chinos" sobre el tema "Índice Stars Allianz y Nuevo Valor".

La rueda de prensa "China Athletes Business Value Index for Chinese Athletes" se celebró el 17 de diciembre

2016-12-26 prnewswire
BEIJING, 26 de diciembre de 2016 /PRNewswire/ -- Una rueda de prensa titulada "Índice de Valor Comercial" sobre el tema de "Stars Allianz Index y Nuevo Valor" que se organizó conjuntamente por la China Youth Care Foundation y Stars Allianz of Sports and Media (Beijing) Co.Ltd. tuvo lugar en el International Exchange Center of Communication University of China el 17 de diciembre de 2016.

Pressekonferenz zum Geschäftswertindex für chinesische Athleten am 17. Dezember

2016-12-26 prnewswire
PEKING, 26. Dezember 2016 /PRNewswire/ -- Am 17. Dezember 2016 fand am internationalen Austauschzentrum der Communication University of China eine Pressekonferenz mit der Überschrift „Marktwertindex für chinesische Athleten" zum Thema „Stars Allianz Index & Neuwert" statt, die gemeinsam von der China Youth Care Foundation und Stars Allianz of Sports and Media (Beijing) Co.Ltd. ausgerichtet wurde.

China Athletes Business Value Index for Chinese Athletes Press Conference Held on Dec. 17th

2016-12-26 prnewswire
BEIJING, Dec. 26, 2016 /PRNewswire/ -- A press conference titled "Commercial Value Index for Chinese Athletes" on the topic of "Stars Allianz Index & New Value" which was jointly organized by China Youth Care Foundation and Stars Allianz of Sports and Media (Beijing) Co.Ltd. was held at the International Exchange Center of Communication University of China on December 17th, 2016.

China dairy Huishan pledges 40,000 cows as collateral for 750m yuan loan programme

2016-11-28 scmp
China Huishan, which owns the biggest number of dairy farms in China, said it plans to raise 750 million yuan through pledging 40,000 of its cows as collateral, while admitting a similar scheme in April ended in failure.

Asia Pacific Market: Stocks end higher

2016-11-25 indiainfoline
Asia Pacific share market finished higher on last trading session of the week, Friday, 25 November 2016, as the Thanksgiving break in the United States helped slow a relentless surge in the dollar that has sucked capital out of most emerging markets. Wall Street was closed on Thursday for the Thanksgiving holiday and trading will end early on Friday.

Turning Canada-China Economic Friendship Into Practical Business Cooperation

2016-10-14 prnewswire
BEIJING, Oct. 14, 2016 /PRNewswire/ -- A China Entrepreneur Club (CEC) delegation will embark on an eight-day journey to Canada from October 16 to 23. This is the 9th destination country for CEC's annual visits, following successful trips to the United States, UK, France, Belgium, Australia, Singapore, Germany, and Italy.

Mengniu Dairy’s interim profit hit hard by bruising price war

2016-08-25 scmp
Net profit tumbles 19.5pc, despite 6.6pc rise in revenue to 27.26 billion yuan. Liquid milk sales jump 8.3pc, yoghurt sales surge 31.6pc

Asia Pacific market: Stocks climb on Japan election result, US jobs data

2016-07-11 indiainfoline
Asia Pacific share market advanced on Monday, 11 July 2016, as risk appetite buying bolstered by election results in Japan and Australia and last week's strong monthly U.S. jobs report which eased concerns over the health of the world's largest economy

Dairy industry reshaped by Asian deals as milk price sours

2016-06-08 reuters
LONDON/SYDNEY, June 8 The global dairy industry is being reshaped by a wave of dealmaking driven by low milk prices and growing demand for products like yoghurt and baby formula in Asia and the Middle East.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

22h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

23h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...